The Enterprise Value as of November 2025 (TTM) for Tissue Regenix Group plc (TRX.L) is 15.48M

According to Tissue Regenix Group plc’s latest financial reports and current stock price. The company's current Enterprise Value is 15.48M. This represents a change of -64.58% compared to the average of 43.70M of the last 4 quarters.

Tissue Regenix Group plc (TRX.L) Historical Enterprise Value (quarterly & annually)

How has TRX.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Tissue Regenix Group plc over the last ten years is 58.94M. The current 15.48M Enterprise Value has changed 2.53% with respect to the historical average. Over the past ten years (40 quarters), TRX.L's Enterprise Value was at its highest in in the June 2012 quarter at 7.82B. The Enterprise Value was at its lowest in in the July 2016 quarter at -17857850.00.

Tissue Regenix Group plc (TRX.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tissue Regenix Group plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tissue Regenix Group plc (TRX.L) Average Enterprise Value

How has TRX.L Enterprise Value performed in the past?

The current Enterprise Value of Tissue Regenix Group plc (TRX.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Tissue Regenix Group plc (TRX.L) Enterprise Value vs. Peers

How is TRX.L’s Enterprise Value compared to its peers?

Tissue Regenix Group plc’s Enterprise Value is greater than CRISM Therapeutics Corporation (5.38M), greater than Theracryf Plc (2.40M), less than Proteome Sciences plc (22.80M), greater than Oxford BioDynamics Plc (6.42M), greater than N4 Pharma Plc (3.06M), greater than Cizzle Biotechnology Holdings Plc (5.98M), greater than Chill Brands Group PLC (6.42M), greater than MyHealthChecked PLC (-504856.00), greater than Surgical Innovations Group plc (6.41M), greater than Roquefort Therapeutics plc (2.19M),

Build a custom stock screener for Tissue Regenix Group plc (TRX.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tissue Regenix Group plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tissue Regenix Group plc (TRX.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tissue Regenix Group plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.